Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof

US9725697B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9725697-B2
Application numberUS-201514708606-A
CountryUS
Kind codeB2
Filing dateMay 11, 2015
Priority dateApr 8, 2010
Publication dateAug 8, 2017
Grant dateAug 8, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides an isolated population of chondrocyte precursor cells wherein 1% or less of the cells express Oct4, Nanog and/or TRA-1-60, 7% or less of the cells express no collagen II, collagen X, CD105 or Stro-1 and 85% or more of the cells express CBFA1, methods for preparing such cells and uses of chondrocyte cells derived from said precursor cells.

First claim

Opening claim text (preview).

The invention claimed is: 1. A population of de-differentiated committed chondrocyte precursor cells, wherein the de-differentiated committed chondrocyte precursor cells are the in vitro progeny of human embryonic stem (hES) cells and characterized by 85% or more of the cells expressing CBFA1 and by the loss of transdifferentiation potential to form osteoblasts when cultured in osteogenic medium. 2. The population of claim 1 , wherein 1% or less of the cells express Oct4, Nanog and/or TRA-1-60. 3. The population of claim 1 , wherein 1% or less of the cells express Ki67. 4. The population of claim 1 , further comprising human embryonic stem (hES) cells, wherein the de-differentiated committed chondrocyte precursor cells are the in vitro progeny of the hES cells. 5. A first and a second population of cells, comprising: a) a first in vitro population of cells comprising human embryonic stem (hES) cells; and b) a second in vitro population of cells comprising de-differentiated committed chondrocyte precursor (DDPC) cells that are the progeny of the hES cells, wherein 85% or more of the DDPCs express CBFA1 and wherein the DDPCs are characterized by the loss of transdifferentiation potential to form osteoblasts when cultured in osteogenic medium.

Assignees

Inventors

Classifications

  • from embryonic cells · CPC title

  • Transforming growth factor beta (TGF-β) · CPC title

  • for joint disorders, e.g. arthritis, arthrosis · CPC title

  • C12N5/0655Primary

    Chondrocytes; Cartilage · CPC title

  • Steroid hormones · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9725697B2 cover?
The present invention provides an isolated population of chondrocyte precursor cells wherein 1% or less of the cells express Oct4, Nanog and/or TRA-1-60, 7% or less of the cells express no collagen II, collagen X, CD105 or Stro-1 and 85% or more of the cells express CBFA1, methods for preparing such cells and uses of chondrocyte cells derived from said precursor cells.
Who is the assignee on this patent?
Univ Court Univ Of Edinburgh
What technology area does this patent fall under?
Primary CPC classification C12N5/0655. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).